Michael P. Hagan

Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233

Raymond H. Mak, Daniel Hunt, William U. Shipley et al. · Journal of Clinical Oncology · 2014 · 452 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06

Jason A. Efstathiou, Kyounghwa Bae, William U. Shipley et al. · Journal of Clinical Oncology · 2009 · 219 citations · Full text

Medicine, Oncology, Urology +14

RTOG 97-06: Initial report of a Phase I–II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy

Michael P. Hagan, Kathryn Winter, Donald S. Kaufman et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 202 citations

Medicine, Oncology, Urology +15

Epidermal Growth Factor and Ionizing Radiation Up-regulate the DNA Repair Genes<i>XRCC1</i>and<i>ERCC1</i>in DU145 and LNCaP Prostate Carcinoma through MAPK Signaling

Adly Yacoub, Robert McKinstry, Darin Hinman et al. · Radiation Research · 2003 · 147 citations

Medicine, Molecular Biology, Oncology +17

Association between coronary heart disease and cancers of the breast, prostate, and colon.

Alfred I. Neugut, David J. Rosenberg, Habibul Ahsan et al. · PubMed · 1998 · 143 citations

Medicine, Oncology, Surgery +15